Clinical Trial Update: Excretion Balance, Pharmacokinetics, and Metabolism Following of [14C]-Venglustat Administration in Healthy Male Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing excretion balance, pharmacokinetics, and metabolism of radiolabeled venglustat in healthy male subjects.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorders of Sphingolipid Metabolism

Drugs mentioned

• Venglustat (venglustat)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Disorders of Sphingolipid Metabolism, Healthy Volunteers | Phase 1 | Status: COMPLETED